| UniProt ID | RAVR1_HUMAN | |
|---|---|---|
| UniProt AC | Q8IY67 | |
| Protein Name | Ribonucleoprotein PTB-binding 1 | |
| Gene Name | RAVER1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 606 | |
| Subcellular Localization | Nucleus. Cytoplasm. Nuclear, in perinucleolar structures. Shuttles between nucleus and cytoplasm. Cytoplasm, at focal contacts and cell-cell contacts. Associated with myotubes during muscle differentiation (By similarity).. | |
| Protein Description | Cooperates with PTBP1 to modulate regulated alternative splicing events. Promotes exon skipping. Cooperates with PTBP1 to modulate switching between mutually exclusive exons during maturation of the TPM1 pre-mRNA (By similarity).. | |
| Protein Sequence | MAADVSVTHRPPLSPKSGAEVEAGDAAERRAPEEELPPLDPEEIRKRLEHTERQFRNRRKILIRGLPGDVTNQEVHDLLSDYELKYCFVDKYKGTAFVTLLNGEQAEAAINAFHQSRLRERELSVQLQPTDALLCVANLPPSLTQQQFEELVRPFGSLERCFLVYSERTGQSKGYGFAEYMKKDSAARAKSDLLGKPLGPRTLYVHWTDAGQLTPALLHSRCLCVDRLPPGFNDVDALCRALSAVHSPTFCQLACGQDGQLKGFAVLEYETAEMAEEAQQQADGLSLGGSHLRVSFCAPGPPGRSMLAALIAAQATALNRGKGLLPEPNILQLLNNLGPSASLQLLLNPLLHGSAGGKQGLLGAPPAMPLLNGPALSTALLQLALQTQGQKKPGILGDSPLGALQPGAQPANPLLGELPAGGGLPPELPPRRGKPPPLLPSVLGPAGGDREALGLGPPAAQLTPPPAPVGLRGSGLRGPLSHFYSGSPTSYFTSGLQAGLKQSHLSKAIGSSPLGSGEGLLGLSPGPNGHSHLLKVRAGGGDMQGWEAPAPQRPLTRPALPSVSRPHWAARNAALPTCCPRPSPAQKAAMWASTPRASAATTRTPT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAADVSVTH ------CCCCCEECC | 16.63 | 20068231 | |
| 6 | Phosphorylation | --MAADVSVTHRPPL --CCCCCEECCCCCC | 23.11 | 25159151 | |
| 8 | Phosphorylation | MAADVSVTHRPPLSP CCCCCEECCCCCCCC | 12.50 | 21955146 | |
| 14 | Phosphorylation | VTHRPPLSPKSGAEV ECCCCCCCCCCCCEE | 35.74 | 29255136 | |
| 16 (in isoform 3) | Ubiquitination | - | 59.14 | 21890473 | |
| 17 | Phosphorylation | RPPLSPKSGAEVEAG CCCCCCCCCCEEECC | 46.77 | 29255136 | |
| 17 (in isoform 2) | Phosphorylation | - | 46.77 | 18669648 | |
| 23 | Phosphorylation | KSGAEVEAGDAAERR CCCCEEECCCHHHHC | 26.75 | 17081983 | |
| 25 | Phosphorylation | GAEVEAGDAAERRAP CCEEECCCHHHHCCC | 50.05 | 17081983 | |
| 30 | Methylation | AGDAAERRAPEEELP CCCHHHHCCCHHHCC | 46.10 | 115490363 | |
| 31 | Phosphorylation | GDAAERRAPEEELPP CCHHHHCCCHHHCCC | 23.29 | 18691976 | |
| 33 | Sumoylation | AAERRAPEEELPPLD HHHHCCCHHHCCCCC | 64.22 | - | |
| 34 | Phosphorylation | AERRAPEEELPPLDP HHHCCCHHHCCCCCH | 64.87 | 18669648 | |
| 47 | Methylation | DPEEIRKRLEHTERQ CHHHHHHHHHHHHHH | 35.14 | - | |
| 80 | Phosphorylation | QEVHDLLSDYELKYC HHHHHHHHCCEEEEE | 45.50 | - | |
| 82 | Phosphorylation | VHDLLSDYELKYCFV HHHHHHCCEEEEEEE | 21.56 | - | |
| 86 | Phosphorylation | LSDYELKYCFVDKYK HHCCEEEEEEEECCC | 12.07 | 28152594 | |
| 91 | 2-Hydroxyisobutyrylation | LKYCFVDKYKGTAFV EEEEEEECCCCEEEE | 43.49 | - | |
| 91 | Acetylation | LKYCFVDKYKGTAFV EEEEEEECCCCEEEE | 43.49 | 26822725 | |
| 92 | Phosphorylation | KYCFVDKYKGTAFVT EEEEEECCCCEEEEE | 15.36 | - | |
| 97 | Phosphorylation | DKYKGTAFVTLLNGE ECCCCEEEEEEECHH | 4.30 | - | |
| 99 | Phosphorylation | YKGTAFVTLLNGEQA CCCEEEEEEECHHHH | 21.05 | - | |
| 102 | Ubiquitination | TAFVTLLNGEQAEAA EEEEEEECHHHHHHH | 55.88 | - | |
| 103 | Phosphorylation | AFVTLLNGEQAEAAI EEEEEECHHHHHHHH | 28.50 | - | |
| 108 | Ubiquitination | LNGEQAEAAINAFHQ ECHHHHHHHHHHHHH | 19.36 | - | |
| 109 | Phosphorylation | NGEQAEAAINAFHQS CHHHHHHHHHHHHHH | 6.25 | - | |
| 157 | Phosphorylation | ELVRPFGSLERCFLV HHHHHCCCCCEEEEE | 27.69 | 26091039 | |
| 175 | Phosphorylation | RTGQSKGYGFAEYMK CCCCCCCCCHHHHHH | 16.89 | 18083107 | |
| 185 | Phosphorylation | AEYMKKDSAARAKSD HHHHHHCHHHHHHHH | 32.48 | 28634120 | |
| 190 | Sumoylation | KDSAARAKSDLLGKP HCHHHHHHHHHCCCC | 38.66 | - | |
| 190 | Ubiquitination | KDSAARAKSDLLGKP HCHHHHHHHHHCCCC | 38.66 | - | |
| 191 | Phosphorylation | DSAARAKSDLLGKPL CHHHHHHHHHCCCCC | 32.29 | 20873877 | |
| 196 | Ubiquitination | AKSDLLGKPLGPRTL HHHHHCCCCCCCCEE | 36.72 | - | |
| 196 (in isoform 1) | Ubiquitination | - | 36.72 | 21890473 | |
| 207 | Sumoylation | PRTLYVHWTDAGQLT CCEEEEEECCHHHCC | 5.97 | - | |
| 207 | Ubiquitination | PRTLYVHWTDAGQLT CCEEEEEECCHHHCC | 5.97 | - | |
| 213 | Ubiquitination | HWTDAGQLTPALLHS EECCHHHCCHHHHHC | 6.40 | - | |
| 213 (in isoform 2) | Ubiquitination | - | 6.40 | 21890473 | |
| 214 | Phosphorylation | WTDAGQLTPALLHSR ECCHHHCCHHHHHCC | 9.91 | - | |
| 231 | Phosphorylation | CVDRLPPGFNDVDAL ECCCCCCCCCHHHHH | 31.86 | - | |
| 243 | Phosphorylation | DALCRALSAVHSPTF HHHHHHHHHHCCCCE | 27.53 | 27067055 | |
| 297 | Glutathionylation | SHLRVSFCAPGPPGR CEEEEEEECCCCCCH | 3.30 | 22555962 | |
| 399 | Phosphorylation | KPGILGDSPLGALQP CCCCCCCCCCCCCCC | 21.89 | 29496963 | |
| 416 | Phosphorylation | QPANPLLGELPAGGG CCCCCCCCCCCCCCC | 41.92 | - | |
| 441 | Phosphorylation | KPPPLLPSVLGPAGG CCCCCCHHHCCCCCC | 29.91 | 24732914 | |
| 451 | Ubiquitination | GPAGGDREALGLGPP CCCCCCHHHCCCCCC | 53.65 | - | |
| 458 | Phosphorylation | EALGLGPPAAQLTPP HHCCCCCCHHHCCCC | 38.13 | 20068231 | |
| 463 | Phosphorylation | GPPAAQLTPPPAPVG CCCHHHCCCCCCCCC | 22.97 | 29255136 | |
| 463 (in isoform 2) | Phosphorylation | - | 22.97 | 18669648 | |
| 472 | Methylation | PPAPVGLRGSGLRGP CCCCCCCCCCCCCCC | 31.16 | 54558519 | |
| 474 | Phosphorylation | APVGLRGSGLRGPLS CCCCCCCCCCCCCCH | 28.37 | 29496963 | |
| 474 (in isoform 2) | Phosphorylation | - | 28.37 | 20068231 | |
| 477 | Methylation | GLRGSGLRGPLSHFY CCCCCCCCCCCHHHC | 48.48 | 81452779 | |
| 480 | Phosphorylation | GSGLRGPLSHFYSGS CCCCCCCCHHHCCCC | 7.47 | 19664995 | |
| 483 (in isoform 2) | Phosphorylation | - | 4.70 | 30266825 | |
| 485 | Phosphorylation | GPLSHFYSGSPTSYF CCCHHHCCCCCCHHH | 31.67 | 20068231 | |
| 487 | Phosphorylation | LSHFYSGSPTSYFTS CHHHCCCCCCHHHHH | 21.04 | 22496350 | |
| 488 (in isoform 2) | Phosphorylation | - | 28.96 | 30266825 | |
| 489 | Phosphorylation | HFYSGSPTSYFTSGL HHCCCCCCHHHHHHH | 37.44 | 25627689 | |
| 491 | Phosphorylation | YSGSPTSYFTSGLQA CCCCCCHHHHHHHHH | 17.22 | 20068231 | |
| 493 (in isoform 2) | Phosphorylation | - | 17.41 | 30266825 | |
| 501 | Methylation | SGLQAGLKQSHLSKA HHHHHHHCHHHHHHH | 49.16 | 115985349 | |
| 502 (in isoform 2) | Phosphorylation | - | 40.92 | 28111955 | |
| 505 | Phosphorylation | AGLKQSHLSKAIGSS HHHCHHHHHHHHCCC | 7.32 | 20068231 | |
| 507 | Acetylation | LKQSHLSKAIGSSPL HCHHHHHHHHCCCCC | 50.84 | 30591765 | |
| 509 (in isoform 2) | Phosphorylation | - | 6.72 | 25884760 | |
| 510 | Phosphorylation | SHLSKAIGSSPLGSG HHHHHHHCCCCCCCC | 27.25 | 20068231 | |
| 511 | Phosphorylation | HLSKAIGSSPLGSGE HHHHHHCCCCCCCCC | 23.75 | 25159151 | |
| 512 | Phosphorylation | LSKAIGSSPLGSGEG HHHHHCCCCCCCCCC | 20.94 | 25159151 | |
| 514 (in isoform 2) | Phosphorylation | - | 10.35 | 28442448 | |
| 516 | Phosphorylation | IGSSPLGSGEGLLGL HCCCCCCCCCCCCCC | 41.16 | 25159151 | |
| 524 | Phosphorylation | GEGLLGLSPGPNGHS CCCCCCCCCCCCCCC | 26.47 | 29255136 | |
| 531 | Phosphorylation | SPGPNGHSHLLKVRA CCCCCCCCEEEEEEE | 19.75 | 29255136 | |
| 544 (in isoform 2) | Phosphorylation | - | 59.60 | - | |
| 553 (in isoform 2) | Phosphorylation | - | 27.43 | 28985074 | |
| 554 (in isoform 2) | Phosphorylation | - | 32.60 | 25262027 | |
| 556 (in isoform 2) | Phosphorylation | - | 36.97 | 25627689 | |
| 562 | Phosphorylation | LTRPALPSVSRPHWA CCCCCCCCCCCCCHH | 33.31 | - | |
| 563 (in isoform 2) | Phosphorylation | - | 5.48 | 22199227 | |
| 567 (in isoform 2) | Phosphorylation | - | 26.20 | 19664994 | |
| 570 (in isoform 2) | Phosphorylation | - | 10.48 | 30266825 | |
| 571 (in isoform 2) | Phosphorylation | - | 26.10 | 25159151 | |
| 574 (in isoform 2) | Ubiquitination | - | 20.02 | 21890473 | |
| 577 | Phosphorylation | ARNAALPTCCPRPSP HHCCCCCCCCCCCCH | 27.82 | 28555341 | |
| 580 | Phosphorylation | AALPTCCPRPSPAQK CCCCCCCCCCCHHHH | 54.05 | 20068231 | |
| 581 | Methylation | ALPTCCPRPSPAQKA CCCCCCCCCCHHHHH | 30.34 | 115490355 | |
| 581 (in isoform 2) | Phosphorylation | - | 30.34 | 27251275 | |
| 583 | Phosphorylation | PTCCPRPSPAQKAAM CCCCCCCCHHHHHHH | 33.86 | 21712546 | |
| 583 (in isoform 2) | Phosphorylation | - | 33.86 | 29116813 | |
| 584 | Phosphorylation | TCCPRPSPAQKAAMW CCCCCCCHHHHHHHH | 41.20 | 19664994 | |
| 584 (in isoform 2) | Phosphorylation | - | 41.20 | 27251275 | |
| 585 (in isoform 2) | Phosphorylation | - | 28.04 | 29116813 | |
| 587 | Methylation | PRPSPAQKAAMWAST CCCCHHHHHHHHHCC | 39.97 | 115976315 | |
| 588 (in isoform 2) | Phosphorylation | - | 7.17 | 21552520 | |
| 590 (in isoform 2) | Phosphorylation | - | 3.52 | 29116813 | |
| 594 | Phosphorylation | KAAMWASTPRASAAT HHHHHHCCCCCCCCC | 14.73 | - | |
| 596 | Methylation | AMWASTPRASAATTR HHHHCCCCCCCCCCC | 41.06 | 115490351 | |
| 601 | Phosphorylation | TPRASAATTRTPT-- CCCCCCCCCCCCC-- | 19.27 | 29396449 | |
| 602 | Phosphorylation | PRASAATTRTPT--- CCCCCCCCCCCC--- | 28.02 | 29396449 | |
| 604 | Phosphorylation | ASAATTRTPT----- CCCCCCCCCC----- | 29.23 | 29396449 | |
| 634 | Phosphorylation | ----------------------------------- ----------------------------------- | 20166139 | ||
| 638 | Phosphorylation | --------------------------------------- --------------------------------------- | 19651622 | ||
| 648 | Phosphorylation | ------------------------------------------------- ------------------------------------------------- | 20068231 | ||
| 658 | Phosphorylation | ----------------------------------------------------------- ----------------------------------------------------------- | 20068231 | ||
| 660 | Phosphorylation | ------------------------------------------------------------- ------------------------------------------------------------- | 20068231 | ||
| 674 | Methylation | --------------------------------------------------------------------------- --------------------------------------------------------------------------- | - | ||
| 684 | Phosphorylation | ------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- | 20068231 | ||
| 685 | Phosphorylation | -------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- | 20068231 | ||
| 689 | Phosphorylation | ------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------ | 20068231 | ||
| 697 | Phosphorylation | -------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- | 20068231 | ||
| 704 | Phosphorylation | --------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- | 20068231 | ||
| 724 | Phosphorylation | ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- | 20068231 | ||
| 728 | Phosphorylation | --------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- | 20068231 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 700 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RAVR1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RAVR1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PUR4_HUMAN | PFAS | physical | 26344197 | |
| GORS2_HUMAN | GORASP2 | physical | 27173435 | |
| UBAP2_HUMAN | UBAP2 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-14 AND THR-463, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-14 AND THR-463, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; THR-463; SER-474;SER-512 AND SER-524, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-567(ISOFORM 2), AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; THR-463; SER-512 ANDSER-524, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-567; SER-617;SER-707 AND SER-711 (ISOFORM 2), AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-463, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-463, AND MASSSPECTROMETRY. | |